Healthcare Economics & Policy

Fujifilm Canada announced Thursday, April 11, that it has established a new division to help increase the availability and sales of the company’s diagnostic imaging systems throughout Canada.

Radiologists earn an average of $419,000 per year, according to Medscape’s Physician Compensation Report 2019. This makes radiology tied for No. 5 among all specialties.

The percentage of radiation oncologists in the United States working in urban and suburban communities is on the rise, according to a new survey published in the International Journal of Radiation Oncology • Biology • Physics. What does this mean for patient care in more rural locations?

Enlitic, a San Francisco-based healthcare company focused on the use of AI in medical imaging, announced Thursday, April 4, that it has closed a $15 million Series B financing round.

Consolidation has led to larger group sizes and fewer groups that focus on a single specialty, according to a new study published in the Journal of the American College of Radiology.

Volpara Solutions, the New Zealand-based breast imaging technology company, announced that GE Healthcare will now be distributing its VolparaDensity software for breast density assessments throughout the world.

The average annual compensation for radiologists in the United States is $429,000, according to a new report from Doximity. Radiology was ranked 10th among all specialties included in the report.  

Royal Philips has acquired Direct Radiology’s teleradiology platform and business operations.

National Mobile X-Ray, a Lakeway, Texas-based mobile imaging provider, announced that it has acquired Asheville, North Carolina-based MMDS Mobile X-Ray.

Carestream Health’s recent decision to sell its healthcare information systems business to Royal Philips has been greeted with a mostly positive reaction from the imaging industry, according to a new market report.

President Trump’s proposed “Budget for a Better America” for 2020 would cut Medicare spending by approximately $845 billion and Medicaid spending by approximately $241 billion over 10 years.

The FDA has granted accelerated approval to the combination of atezolizumab, an antibody marketed by Genentech under the name Tecentriq, and chemotherapy for certain patients with metastatic triple-negative breast cancer.